Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 12, 2025, titled "Senores Pharmaceuticals acquires ANDAs from Teva Pharmaceuticals USA, Inc.".
Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 12, 2025, titled "Senores Pharmaceuticals acquires ANDAs from Teva Pharmaceuticals USA, Inc.".